Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-430-4 | CAS number: 24720-09-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From December 19, 1978 to March 28, 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- The study was performed prior to the OECD Test Guideline No. 401 but the protocol is similar to that guidance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- environmental conditions not reported
- Principles of method if other than guideline:
- Acute gavage administration to rats.
- GLP compliance:
- no
- Remarks:
- pre-GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- (E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one
- EC Number:
- 246-430-4
- EC Name:
- (E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one
- Cas Number:
- 24720-09-0
- Molecular formula:
- C13H20O
- IUPAC Name:
- 1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): 78-057-01
- Physical state: Light yellow colored liquid
- Storage condition of test material: Stored at 5 °C in the glass bottle.
- Other: Specific gravity: 0.8703 at room temperature.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Wilmington, Massachusetts.
- Weight at study initiation: 135-219 g (range-finding study); 136-202 g (main study).
- Fasting period before study: Prior to dosing all animals were fasted overnight. After dosing, food was withheld for one hour after which it was available ad libitum.
- Housing: Animals were housed individually in suspended stainless steel cages.
- Diet: Purina Rodent Laboratory Chow®#5001, ad libitum
- Water: Water, ad libitum
- Acclimation period: 7 days
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
DOSAGE PREPARATION (if unusual): Based on a specific gravity of 0.8703 appropriate amounts of test material was admixed with corn oil to achieve required dose levels. Dosing solutions were agitated prior to administration to each animal. - Doses:
- Main study: 1000, 1470, 2150, 3160, 4640 mg/kg bw
- No. of animals per sex per dose:
- 5 animals/sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Animals were observed for mortality and signs of toxicity at 1, 3, 6 and 24 h after dosing and daily thereafter for 14 days. Individual body weights were recorded prior to dosing and at time of death or sacrifice on Day 14.
- Necropsy of survivors performed: Yes, all surviving animals were sacrificed using T-61®Euthanasia Solution (National Laboratories Corporation, Somerville, N. J.) on Day 14 and necropsies were performed on all animals at the time of death or sacrifice. - Statistics:
- Litchfield and Wilcoxon (1949).
Results and discussion
- Preliminary study:
- Not applicable
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 500 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 940 - 2 450
- Remarks on result:
- other: 1/5, 3/5, 3/5, 5/5 and 5/5 females died at 1000, 1470, 2150, 3160 and 4640 mg/kg bw, respectively.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 800 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 200 - 2 700
- Remarks on result:
- other: 1/5, 1/5, 3/5, 5/5 and 5/5 males died at 1000, 1470, 2150, 3160 and 4640 mg/kg bw, respectively.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 670 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 970 - 2 900
- Remarks on result:
- other: 2/10, 4/10, 6/10, 10/10 and 10/10 animals died at 1000, 1470, 2150, 3160 and 4640 mg/kg bw, respectively.
- Mortality:
- 2/10 (1 male + 1 female), 4/10 (1 male + 3 females), 6/10 (3 males + 3 females), 10/10 (5 females + 5 males) and 10/10 (5 females + 5 males) animals were died at 1000, 1470, 2150, 3160 and 4640 mg/kg bw, respectively.
- Clinical signs:
- other: Soft, mucoid feces were frequently observed in animals at all dose levels between 1 h and 4 days after dosing. A roughening of the coat was also observed on Days 2 through 4 in two females dosed with 2150 mg/kg bw and on Day 2 in one female dosed with 316
- Gross pathology:
- Gross pathology findings were similar in all of the found-dead animals. No gross tissue alterations attributable to treatment were observed in any of the animals. Presence of the compound was observed in the stomach of all of the found dead animals and the cecum was found to be full of fecal matter. Other frequent observations were a wet, fecal stained anal region and a crust on the nose, mouth and or forepaws. Sacrifice of the animals surviving on Day 14 revealed only mottled lungs which are believed to be an artefact of euthanasia with T-61® Euthanasia Solution.
- Other findings:
- None
Any other information on results incl. tables
Range-finding study:
- Mortality: Two male animals dosed with 1600 mg/kg bw and four animals (2 males + 2 females) dosed with 5000 mg/kg bw died within 3 days after dosing.
- Clinical signs: All animals were observed to have soft feces antemortem. Except for occasional soft feces, no signs of toxicity were observed in animals dosed with 50, 160 or 500 mg/kg bw.
- Gross pathology: Gross pathology revealed the presence of the compound in the stomach of all of the found dead animals and generally the cecum contained soft stool.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under the test conditions, the oral LD50(Combined) is 1670 mg/kg bw, therefore the test material is classified to ‘Category 4’ according to the annex VI of the Regulation EC No. 1272/2008 (CLP) and to the GHS.
- Executive summary:
In an acute oral toxicity study, groups of CD® Sprague-Dawley outbred albino rats (5/sex/dose) were administered a single oral (gavage) dose of test material diluted in corn oil at 1000, 1470, 2150, 3160 and 4640 mg/kg bw. Animals were then observed for mortality, clinical signs and bodyweights for 14 days and at the end of the study the surviving animals were sacrificed for macroscopic examination. A range finding study was conducted at the dose levels of 50, 160, 500, 1600 and 5000 mg/kg bw (2/sex/dose) to determine the dose levels for main study.
In the range-finding study, mortality was observed at 1600 and 5000 mg/kg bw in two males and four animals (2 males + 2 females), respectively. In the main study, 2/10 (1 male + 1 female), 4/10 (1 male + 3 females), 6/10 (3 males + 3 females), 10/10 (5 females + 5 males) and 10/10 (5 females + 5 males) animals were died at 1000, 1470, 2150, 3160 and 4640 mg/kg bw, respectively. Soft, mucoid feces were frequently observed in animals at all dose levels between 1 h and 4 days after dosing. A roughening of the coat was also observed on Days 2 through 4 in two females dosed with 2150 mg/kg bw and on Day 2 in one female dosed with 3160 mg/kg bw. All surviving animals dosed with 1000, 1470 and 2150 mg/kg bw appeared normal by Day 6 after dosing. An increase in body weight was noted in all animals surviving to Day 14. Conversely, a decrease in body weight was found in all animals dying prior to Day 14. No gross tissue alterations attributable to treatment were observed in any of the animals.
Oral LD50 Combined = 1670 mg/kg bw (95 % confidence limits of 970-2900 mg/kg bw).
Under the test conditions, the test material is classified to ‘Category 4’ according to the annex VI of the Regulation EC No. 1272/2008 (CLP) and to the GHS.
This study is considered as acceptable and satisfies the requirement for acute oral toxicity endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.